Screener
Stoke Therapeutics, Inc. STOK Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
FAQ
- What is Stoke Therapeutics, Inc.'s asset turnover?
- Stoke Therapeutics, Inc. (STOK) reported asset turnover of 0.1× in Q1 2026.
- How has Stoke Therapeutics, Inc.'s asset turnover changed year-over-year?
- Stoke Therapeutics, Inc.'s asset turnover decreased by 87.9% year-over-year, from 0.6× to 0.1×.
- What is the long-term trend for Stoke Therapeutics, Inc.'s asset turnover?
- Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s asset turnover has grown at a 120.2% compound annual growth rate (CAGR), from 0.1× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Stoke Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude